Skip to content

Avanos Medical AVNS Deferred Taxes

Deferred Taxes at other companies

Stryker logo
StrykerSYK
-$33M-336%
Cardinal Health logo
Cardinal HealthCAH
$60.75M+334%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$1.73M+23.8%
Medtronic logo
MedtronicMDT
$167M+89.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$968K-79.6%
IAR
Integra LifeSciencesIART
$1.33M+172%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's deferred taxes?
Avanos Medical (AVNS) reported deferred taxes of $2.5M in Q1 2026.
How has Avanos Medical's deferred taxes changed year-over-year?
Avanos Medical's deferred taxes decreased by 19.4% year-over-year, from $3.1M to $2.5M.
What is the long-term trend for Avanos Medical's deferred taxes?
Over 4 years (2021 to 2025), Avanos Medical's deferred taxes has grown at a 19.7% compound annual growth rate (CAGR), from $3.8M to -$7.8M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.